1. Home
  2. CERO vs BON Comparison

CERO vs BON Comparison

Compare CERO & BON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERO
  • BON
  • Stock Information
  • Founded
  • CERO 2017
  • BON 2006
  • Country
  • CERO United States
  • BON China
  • Employees
  • CERO N/A
  • BON N/A
  • Industry
  • CERO
  • BON Medicinal Chemicals and Botanical Products
  • Sector
  • CERO
  • BON Health Care
  • Exchange
  • CERO Nasdaq
  • BON Nasdaq
  • Market Cap
  • CERO 5.6M
  • BON 5.9M
  • IPO Year
  • CERO N/A
  • BON 2021
  • Fundamental
  • Price
  • CERO $5.43
  • BON $1.88
  • Analyst Decision
  • CERO Strong Buy
  • BON
  • Analyst Count
  • CERO 2
  • BON 0
  • Target Price
  • CERO $45.00
  • BON N/A
  • AVG Volume (30 Days)
  • CERO 306.0K
  • BON 3.3M
  • Earning Date
  • CERO 08-22-2025
  • BON 01-28-2026
  • Dividend Yield
  • CERO N/A
  • BON N/A
  • EPS Growth
  • CERO N/A
  • BON N/A
  • EPS
  • CERO N/A
  • BON 4.17
  • Revenue
  • CERO N/A
  • BON $23,844,556.00
  • Revenue This Year
  • CERO N/A
  • BON $223.38
  • Revenue Next Year
  • CERO N/A
  • BON $18.82
  • P/E Ratio
  • CERO N/A
  • BON $0.44
  • Revenue Growth
  • CERO N/A
  • BON N/A
  • 52 Week Low
  • CERO $4.27
  • BON $1.14
  • 52 Week High
  • CERO $895.40
  • BON $73.75
  • Technical
  • Relative Strength Index (RSI)
  • CERO 32.53
  • BON 72.02
  • Support Level
  • CERO $4.27
  • BON $1.73
  • Resistance Level
  • CERO $5.65
  • BON $1.97
  • Average True Range (ATR)
  • CERO 0.54
  • BON 0.20
  • MACD
  • CERO -0.17
  • BON 0.05
  • Stochastic Oscillator
  • CERO 31.12
  • BON 26.21

About CERO CERo Therapeutics Holdings Inc. Common Stock

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand.

About BON Bon Natural Life Limited

Bon Natural Life Ltd is engaged in the manufacturing of personal care ingredients, such as plants extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. Xi'an App-Chem is devoted to providing high quality and competitive prices and a stable supply of products and services for the functional food, personal care, natural medicine and other industries. It provides these products and services for third party customers, as well as for its own proprietary brands. The company has its geographic presence in PRC and in Overseas. The company derives maximum revenue from Bioactive food ingredients.

Share on Social Networks: